A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation

BACKGROUND: The benefits of low-dose ketamine for patients with treatment-resistant depression (TRD) and prominent suicidal ideation require further investigation. The effects of treatment refractoriness, the duration of the current depressive episode, and the number of prior antidepressant failures...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Tung-Ping, Li, Cheng-Ta, Lin, Wei-Chen, Wu, Hui-Ju, Tsai, Shih-Jen, Bai, Ya-Mei, Mao, Wei-Chung, Tu, Pei-Chi, Chen, Li-Fen, Li, Wei-Chi, Chen, Mu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229851/
https://www.ncbi.nlm.nih.gov/pubmed/36966411
http://dx.doi.org/10.1093/ijnp/pyad014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229851/
https://www.ncbi.nlm.nih.gov/pubmed/36966411
http://dx.doi.org/10.1093/ijnp/pyad014

Ejemplares similares